Houston Medical Research Institute, LLC

Houston, Texas 77074

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Proteinuric Kidney Disease

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now